Mannkind (MNKD) Net Income Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 12.59% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -115.33% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -290.15% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 59.59% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -73.01% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -10.08% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1,228.66% |
| 10 | Mannkind | 1.09 Bn | 956.66 Mn | 82.66 Mn | -226.30% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -226.30% |
| Dec 31, 2025 | -381.82% |
| Sep 30, 2025 | -30.90% |
| Jun 30, 2025 | 133.55% |
| Mar 31, 2025 | 23.78% |
| Dec 31, 2024 | 427.01% |
| Sep 30, 2024 | 571.12% |
| Jun 30, 2024 | 62.18% |
| Mar 31, 2024 | 208.52% |
| Dec 31, 2023 | 107.84% |
| Sep 30, 2023 | 111.92% |
| Jun 30, 2023 | 81.86% |
| Mar 31, 2023 | 62.32% |
| Dec 31, 2022 | 36.04% |
| Sep 30, 2022 | -226.07% |
| Jun 30, 2022 | 18.30% |
| Mar 31, 2022 | -101.29% |
| Dec 31, 2021 | -6.25% |
| Sep 30, 2021 | 60.68% |
| Jun 30, 2021 | -246.50% |
| Mar 31, 2021 | -38.55% |
| Dec 31, 2020 | -97.04% |
| Sep 30, 2020 | -8.53% |
| Jun 30, 2020 | 17.24% |
| Mar 31, 2020 | 37.36% |
| Dec 31, 2019 | -85.57% |
| Sep 30, 2019 | 57.09% |
| Jun 30, 2019 | 45.37% |
| Mar 31, 2019 | 51.02% |
| Dec 31, 2018 | -108.93% |
| Sep 30, 2018 | 26.51% |
| Jun 30, 2018 | 35.84% |
| Mar 31, 2018 | -86.14% |
| Dec 31, 2017 | 49.88% |
| Sep 30, 2017 | -125.99% |
| Jun 30, 2017 | -17.96% |
| Mar 31, 2017 | 34.37% |
| Dec 31, 2016 | -33.39% |
| Sep 30, 2016 | 497.15% |
| Jun 30, 2016 | -3.63% |
| Mar 31, 2016 | 18.87% |
| Dec 31, 2015 | 322.35% |
| Sep 30, 2015 | 12.77% |
| Jun 30, 2015 | 60.59% |
| Mar 31, 2015 | 41.11% |
| Dec 31, 2014 | 31.99% |
| Sep 30, 2014 | 28.14% |
| Jun 30, 2014 | -59.06% |
| Mar 31, 2014 | -27.07% |
| Dec 31, 2013 | -3.48% |
| Sep 30, 2013 | -18.64% |
| Jun 30, 2013 | -26.10% |
| Mar 31, 2013 | -7.31% |
| Dec 31, 2012 | -42.27% |
| Sep 30, 2012 | -11.54% |
| Jun 30, 2012 | 17.77% |
| Mar 31, 2012 | 8.07% |
| Dec 31, 2011 | 4.98% |
| Sep 30, 2011 | 15.23% |
| Jun 30, 2011 | -5.28% |